4//SEC Filing
ADAMIS ANTHONY P 4
Accession 0001562180-24-000391
CIK 0001314102other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 8:53 PM ET
Size
5.6 KB
Accession
0001562180-24-000391
Insider Transaction Report
Form 4
ADAMIS ANTHONY P
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-01-05+25,014→ 25,014 totalExercise: $20.40From: 2025-01-05Exp: 2034-01-04→ Common Stock (25,014 underlying)
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001277479
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 8:53 PM ET
- Size
- 5.6 KB